Routine screening of antenatal population for thyroid disorders-mandatory
Keywords:Pregnancy, Thyroid disorders, Universal screening
Background: Thyroid dysfunction is commonly seen in pregnant women causing adverse maternal and fetal effects. Routine screening of antenatal population for the same will be helpful for successful pregnancy outcomes. The objective of this study is to detect and treat antenatal women with Thyroid dysfunction to avoid deleterious maternal/ fetal effects.
Methods: The present study is a hospital based prospective study conducted in the department of Obstetrics and Gynaecology of Narayana Medical College and Hospital(NMCH), Nellore, Andhra Pradesh, India. 1000 pregnant women were randomly recruited into this study. Apart from routine antenatal investigations, Thyroid function tests (TFT) - Thyroid stimulating hormone (TSH), freeT4 (fT4) and Thyroid peroxidase antibody (TPO Ab) are done for all the recruited women at the first visit of antenatal booking and individual Thyroid tests are repeated as required.
Results: Following the TFT the study population is classified into pregnancies with euthyroidism‚ subclinical/ overt hypothyroidism and hyperthyroidism. The prevalence of Thyroid disorders in present study was 12.7% of which hypothyroidism noted in 10.3% (subclinical 6.9% and overt 3.4%) while hyperthyroidism seen in 2.4% (subclinical 1.8% and overt 0.6%). The various pregnancy complications, labour and neonatal outcomes have been analyzed.
Conclusions: Thyroid dysfunction in pregnancy affects the health of the mother as well as the baby. Screening for Thyroid dysfunction should be performed as part of the routine antenatal work-up for successful pregnancy outcomes.
Endocrine society clinical practice guidelines-2007.
Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchison S et al. Detection of Thyroid dysfunction in early pregnancy. Universal screening or high risk targeted case Finding. J Clin Endocronol Metab. 2007;92(1):203-7.
Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New England J Med. 1999 Aug;341(8):549-55.
El Baba KA, Azar ST. Thyroid dysfunction in pregnancy. Int J Gen Med. 2012;5:227.
Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21:1081-125.
Sahu MT, Das V, Mittal S, Agarwal A, Sahu M. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet. 2010 Feb 1;281(2):215.
Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline. The J clinical Endocrinol Metabol. 2007 Aug;92(8_supplement):s1-7.
Saki F, Dabbaghmanesh MH, Ghaemi SZ, Forouhari S, Omrani GR, Bakhshayeshkaram M. Thyroid function in pregnancy and its influences on maternal and fetal outcomes. Int J Endocrinol Metabol. 2014 Oct;12(4).
Cho MK. Thyroid dysfunction and subfertility. Clinc Exp Reprod Potential. 2015 Dec; 42(4): 131-5.
Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18:988-1028.
Leung AS, Millar LK, Kooning PP, Montorom, Mestman J. Perinatal outcomes in hypothyroid pregnancies. Obstet Gynecol. 1993;81(3):349-53.
Inversetti A, Serafini A, Manzoni MF, Dolcetta Capuzzo A, Valsecchi L, Candiani M. Severe hypothyroidism causing pre-eclampsia-like syndrome. Case Reports Endocrinol. 2012;2012.
Stabouli S, Papakatsika S, Kotsis V. Hypothyroidism and hypertension. Expert Review Cardiovas Therapy. 2010 Nov;8(11):1559-65.
Chan S, Franklyn J, Loubiere L. Thyroid disorders and growth restriction in pregnancy: could a newly discovered protein hold the key to better treatment? Available at: https://www.action.org.uk/our-research/thyroid-disorders-and-growth-restriction-pregnancy-could-newly-discovered-protein-hold-
Vargova V‚ Macekova D‚ Kraus V et al. Association of thyroid gland disease with intrauterine growth retardation and fetal hypotrophy. 2013:105-15.
Kriplani A, Buckshee K, Bhargava VL, Takkar D, Ammini AC. Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy. European J Obstet Gynecol Reprod Biol. 1994 May;54(3):159-63.
Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005 Feb;105(2):239-45.
Glinoer D. Miscarriage in Women with Positive Anti-TPO Antibodies: Is Thyroxine the Answer?. The J Clinical Endocrinol Metabol. 2006;91(7):2500-2.
Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. The J Clinical Endocrinol Metabol. 2010 Apr;95(4):1699-707.
Muthukrishnan J, Verma A, HariKumar KVS, Ugala M. Indian J Endocrinol Metab. 2013;17(2):294-7.
Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. The J Clinical Endocrinol Metabol. 2010 Sep;95(9):E44-8.
Männistö T, Mendola P, Grewal J, Xie Y, Chen Z, Laughon SK. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. J Clinical Endocrinol Metabol. 2013 Jul;98(7):2725-33.
Grigoriu C, Cezar C, Grigoras M, Horhoianu I, Parau C, Vîrtej P, et al. Management of hyperthyroidism in pregnancy. J Medic Life. 2008 Nov 15;1(4):390.
Ogilvy-Stuart AL. Neonatal thyroid disorders. Arch Dis Childhood-Fetal Neonatal Ed. 2002 Nov;87(3):F165-71.